| Date | Time | Source | Headline | Symbol | Company |
| 04/06/2020 | 9:00AM | GlobeNewswire Inc. | GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solut... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 03/31/2020 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (can... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 03/13/2020 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLE... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 03/02/2020 | 11:14AM | GlobeNewswire Inc. | JAMA Neurology Publishes Results from Positive Phase 3 Trial of EPIDIOLEX® (cannabidiol) oral solution in Children with Seiz... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 02/25/2020 | 4:01PM | GlobeNewswire Inc. | GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 02/24/2020 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 02/12/2020 | 8:11AM | GlobeNewswire Inc. | GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 3... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 02/03/2020 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for Epidiolex® (cannabidio... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 01/12/2020 | 6:00PM | GlobeNewswire Inc. | GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 01/07/2020 | 1:13PM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 12/07/2019 | 12:00PM | GlobeNewswire Inc. | Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberou... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 12/05/2019 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at th... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 11/22/2019 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at Upcoming Investor Conferences | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 11/10/2019 | 7:01PM | GlobeNewswire Inc. | GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of sei... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 11/06/2019 | 7:17PM | Dow Jones News | ADRs Fall Wednesday, Vale and GW Pharmaceuticals Trade Actively | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 11/05/2019 | 4:00PM | GlobeNewswire Inc. | GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019 | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 10/31/2019 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at Upcoming Investor Conferences | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 10/09/2019 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30, 2019 a... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 09/27/2019 | 5:57PM | Dow Jones News | ADRs Close Mixed Friday; GW Pharma, Ctrip, Carnival Plc Actively Traded | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 09/24/2019 | 12:38PM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2nd, 2019 | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 09/23/2019 | 7:00AM | GlobeNewswire Inc. | GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patie... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 09/04/2019 | 8:22AM | GlobeNewswire Inc. | GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 20... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 08/12/2019 | 12:08PM | InvestorsHub NewsWire | Leveraging Cannabinoids in Pediatric Medicine | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 08/06/2019 | 4:01PM | GlobeNewswire Inc. | GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019 | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 07/26/2019 | 6:37AM | GlobeNewswire Inc. | GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures ... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 07/23/2019 | 1:27PM | GlobeNewswire Inc. | GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending June 30, 2019 and Host Conf... | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 07/16/2019 | 8:45AM | InvestorWire | With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 06/27/2019 | 8:00AM | GlobeNewswire Inc. | Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 06/20/2019 | 8:45AM | InvestorWire | Acquisitions, Licenses, Research Key in Consistent Cannabis Market Growth | NASDAQ:GWPH | GW Pharmaceuticals PLC |
| 06/11/2019 | 8:45AM | InvestorWire | Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments | NASDAQ:GWPH | GW Pharmaceuticals PLC |